Guardion Health Sciences, Inc.
2925 Richmond Avenue, Suite 1200
Houston, Texas 77098
| May 1, 2024 |
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jimmy McNamara
| Re: | Guardion Health Sciences, Inc. | |
| Registration Statement on Form S-3 | ||
| File No. 333-278470 |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Guardion Health Sciences, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Friday, May 3, 2024, or as soon thereafter as possible.
Please notify David Sunkin of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (310) 228-2279 or DSunkin@sheppardmullin.com as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
| GUARDION HEALTH SCIENCES, INC. | ||
| By: | /s/ Jan Hall | |
| Name: | Jan Hall | |
| Title: | Chief Executive Officer | |